Sign In
Search Icon
Menu Icon

Thursday, March 28, 2023

Contact ASPR Press Office

ASPR Releases Public Health Emergency Medical Countermeasure Enterprise Multiyear Budget Assessment

ASPR Releases Public Health Emergency Medical Countermeasure Enterprise Multiyear Budget Assessment

Today, the Administration for Strategic Preparedness and Response (ASPR) released the Public Health Emergency Medical Countermeasure Enterprise (PHEMCE) Multiyear Budget (MYB) for fiscal years 2022-2026. The report assesses budget needs to support medical countermeasure priorities which would allow the U.S. Government to prepare for the next public health threat. The multiyear budget projects an estimated overall funding need of $64 billion over the five-year period.

“HHS’ recent responses to COVID-19, mpox, and Ebola, demonstrate the importance of a strong domestic medical countermeasure enterprise,” said Assistant Secretary for Preparedness and Response Dawn O’Connell. “As the first PHEMCE multiyear budget released since the start of the COVID-19 pandemic, it will serve as a useful tool for Congress to gauge ASPR’s funding levels to provide the country protection against whatever comes next.”

The PHEMCE is an interagency body that reviews the current threat landscape and makes recommendations to the Secretary of the U.S. Department of Health and Human Services on available or future medical countermeasures. This MYB was built over a period of time in which there were continuing resolutions, omnibus spending bills, and a near-simultaneously released President’s budget—this MYB is indicative of the assessed need and does not substitute for requested levels in the President’s Budget.

The multiyear budget also provides Congress and external stakeholders with funding information related to investments made in specified threats. The report highlights key priorities — from supporting innovative approaches to MCM development, to fostering clear, scientifically supported regulatory pathways for MCMs, to ensuring our national security.

The report, which picks up in 2022 – where the last MYB left off, estimates a gap of $35.3 billion between the flat fiscal year 2022 level and projected five-year total.  ASPR looks forward to working with Congress to overcome challenges and ensure America is prepared for whatever threat is around the corner.


FY 2022

FY 2023

FY 2024

FY 2025

FY 2026


NIH $2,835 $2,825 $3,065 $3,131 $3,199 $15,055
ASPR BARDA $1,818 $1,973 $13,192 $12,394 $10,928 $40,305
ASPR SNS $845 $975 $1,963 $1,588 $1,439 $6,809
FDA $216 $224 $371 $519 $527 $1,857
Total $5,714 $5,997 $18,590 $17,632 $16,093 $64,025

Collectively, the priorities identified in the budget will build capabilities to allow us to respond faster and more effectively to whatever comes next and advance the development of medical countermeasures. Read the full multiyear budget here

# # #